Down-Regulation of TIMP3 leads to increase in TACE expression and TNFα production by Placental trophoblast cells

American Journal of Reproductive Immunology

Volumn 71, Issue 5, 2014, Pages 427-433

  Ma, Rong ^a,b   Gu, Baihan ^a   Gu, Yang ^a   Groome, Lynn J ^a   Wang, Yuping ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Preeclampsia; TACE; TIMP3; TNF ; Trophoblast

Indexed keywords

ADAM PROTEIN; SMALL INTERFERING RNA; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

AGONISTS; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PREECLAMPSIA; PREGNANCY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TROPHOBLAST;

ADAM PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PRIMARY CELL CULTURE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898831117     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12205     Document Type: Article

References (25)

1. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819-835.
2. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 2004; 89:812-822.
3. Todt JC, Yang Y, Lei J, Lauria MR, Sorokin Y, Cotton DB, Yelian FD: Effects of tumor necrosis factor-alpha on human trophoblast cell adhesion and motility. Am J Reprod Immunol 1996; 36:65-71.
4. Wang Y, Walsh SW: TNFa concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157-169.
5. Benyo DF, Miles TM, Conrad KP: Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997; 82:1582-1588.
6. Conrad KP, Benyo DF: Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37:240-249.
7. Malek A, Sager R, Schneider H: Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta 2001; 22(Suppl A):S45-S50.
8. Pijnenborg R, McLaughlin PJ, Vercruysse L, Hanssens M, Johnson PM, Keith JC Jr, Van Assche FA: Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998; 19:231-239.
9. Ma R, Gu Y, Groome LJ, Wang Y: ADAM17 regulates TNFα production by placental trophoblasts. Placenta 2011; 32:975-980.
10. Pohar N, Godenschwege TA, Buchner E: Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. Genomics 1999; 15:293-296.
11. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knäuper V, Docherty AJ, Murphy G: The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000; 19:275-279.
12. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knäuper V, Docherty AJ, Murphy G: TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435:39-44.
13. Gu Y, Lewis DF, Wang Y: Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008; 93:260-266.
14. Kamiya T, Hara H, Inagaki N, Adachi T: The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytes. Redox Rep 2010; 15:131-134.
15. Hayashi M, Sakata M, Takeda T, Yamamoto T, Okamoto Y, Sawada K, Kimura A, Minekawa R, Tahara M, Tasaka K, Murata Y: Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004; 183:145-154.
16. Tulsawani R, Kelly LS, Fatma N, Chhunchha B, Kubo E, Kumar A, Singh DP: Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage. BMC Neurosci 2010; 125:125.
17. Bowen RS, Zhang Y, Gu Y, Lewis DF, Wang Y: Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta 2005; 26:402-409.
18. Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y: Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig 2005; 12:428-432.
19. Li H, Gu B, Zhang Y, Lewis DF, Wang Y: Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005; 25:210-217.
20. Liu H, Chen SE, Jin B, Carson JA, Niu A, Durham W, Lai JY, Li YP: TIMP3: a physiological regulator of adult myogenesis. J Cell Sci 2010; 123:2914-2921.
21. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R: Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004; 36:969-977.
22. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, Khokha R: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 2006; 176:721-725.
23. Kassiri Z, Oudit GY, Kandalam V, Awad A, Wang X, Ziou X, Maeda N, Herzenberg AM, Scholey JW: Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol 2009; 20:1223-1235.
24. Basu R, Lee J, Wang Z, Patel VB, Fan D, Das SK, Liu GC, John R, Scholey JW, Oudit GY, Kassiri Z: Loss of TIMP3 selectively exacerbates diabetic nephropathy. Am J Physiol Renal Physiol 2012; 303:F1341-F1352.
25. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, Lee DC, Khokha R, Accili D, Lauro R: Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 2005; 115:3494-3505.